Transgene Biotek Share Price
01 Oct, 2026 4:01 PM (IST)
Transgene Biotek Performance
- Today's Low
- ₹2
- Today's High
- ₹3
- 52 Week Low
- ₹2
- 52 Week High
- ₹4
- Open Price₹3
- Previous Close₹3
- Volume61,442
- 50 DMA₹2.80
- 100 DMA₹2.90
- 200 DMA₹3.00
Transgene Biotek Chart
Investment Returns
- Over 1 Month -17.31%
- Over 3 Month -22.77%
- Over 6 Month + 18.18%
- Over 1 Year -40.91%
Smart Investing Starts Here Start SIP with Transgene Biotek for Steady Growth!
Transgene Biotek Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -11
- PEG Ratio
- 0.5
- Market Cap Cr
- 18
- P/B Ratio
- 2.2
- Average True Range
- 0.2
- EPS
- -0.2
- Dividend Yield
- 0
- MACD Signal
- -0.1
- RSI
- 34.48
- MFI
- 20.53
Latest Stock News Updates
Intimation Extension of time for holding 36th Annual General Meeting of the Company for the Financial year ended on March 31, 2026.
- BSE India
- 6 days 8 hours ago
Intimation of Resignation of Statutory Auditors-M/s. Vasavi & Co., Chartered Accountants (FRN:020965S).
- BSE India
- 1 week 1 day ago
Closure of Trading Window
- BSE India
- 1 week 2 days ago
Transgene Biotek Financials
Transgene Biotek Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹2.70
- 50 Day
- ₹2.80
- 100 Day
- ₹2.90
- 200 Day
- ₹3.00
Resistance and Support
- R3 3.00
- R2 2.90
- R1 2.60
- S1 2.20
- S2 2.10
- S3 1.90
Transgene Biotek Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-07 | Quarterly Results & Others | |
| 2026-05-29 | Audited Results | |
| 2026-02-13 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-08-07 | Quarterly Results |
About Transgene Biotek
Transgene Biotek is an Indian public biotech firm, established in 1990, focused on R&D for vaccines, oncology, biogenerics, and novel drug delivery (oral/nasal proteins/peptides) for unmet needs, exporting to various global markets and developing treatments for cancer, auto-immune issues, etc View More- NSE Symbol
- TRABI
- BSE Symbol
- 526139
- ISIN
- INE773D01018
Similar Stocks to Transgene Biotek
Popular Stocks
Transgene Biotek FAQs
Transgene Biotek share price is ₹2 As on 01 October, 2026 | 19:53
The Market Cap of Transgene Biotek is ₹17.7 Cr As on 01 October, 2026 | 19:53
The P/E ratio of Transgene Biotek is -11 As on 01 October, 2026 | 19:53
The PB ratio of Transgene Biotek is 2.2 As on 01 October, 2026 | 19:53
The 52 week High & Low of Transgene Biotek is ₹4.4/₹1.8 respectively As on 01 October, 2026 | 19:53
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.